Dolutegravir/Rilpivirine Combination Drug Market Dolutegravir/rilpivirine is the first two-drug single-tablet regimen (STR) to be approved for the treatment of HIV-1…
Dolutegravir and Its Combination Drug Market Dolutegravir (DTG), sold under the brand name Tivicay, is an antiretroviral medication used, together with other medication, to…